Seronegative rheumatoid arthritis where the affected joint site is not documented or cannot be specified — used when RF (rheumatoid factor) is negative or absent from lab results and no single anatomic site is identified.

Documentation tips

What should appear in the chart to support M06.00.

Source · Editorial brief grounded in 5 cited references ↓

• Record the RF test result explicitly (negative or not detected) or use the term 'seronegative' — this is what justifies M06.0x over M05.x or M06.9.
• If any joint is clinically identified as involved, name it by laterality and anatomic site so a site-specific M06.01x–M06.07x code can be used instead of M06.00.
• Document anti-CCP antibody status when available; a negative anti-CCP alongside negative RF strengthens the seronegative RA diagnosis and supports medical necessity for DMARD therapy.
• Note the clinical basis for the RA diagnosis (synovitis pattern, duration of morning stiffness, imaging findings) since seronegative RA lacks the confirmatory lab marker and is more audit-vulnerable.
• If multiple joints are involved and documented, specify 'multiple sites' rather than leaving site unspecified — this supports M06.09 and more accurately reflects disease burden for prior authorization purposes.

Related CPT procedures

Procedure codes commonly billed with M06.00. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M06.00 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Using M06.00 when the provider documents a specific joint — always step up to the site-specific code (e.g., M06.011 for right shoulder); M06.00 is not a default for all seronegative RA.
• Assigning M06.9 (RA, unspecified) when seronegative status is documented — M06.9 is for unknown serological status, not confirmed seronegative; using it when RF-negative is documented is an undercoding error.
• Confusing M06.00 (seronegative, unspecified site) with M06.09 (seronegative, multiple sites) — use M06.09 when the note documents involvement of more than one named joint.
• Coding M06.0x when the RF result is positive — positive RF directs to the M05.x category regardless of other factors; never use M06.0x for seropositive RA.
• Omitting Z79 long-term medication codes (e.g., Z79.899 for biologic or DMARD therapy) when applicable — payers and prior authorization reviewers expect these to accompany an active RA diagnosis.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M06.0 (laterality / anatomic variants).